Evidence map›Paper›PMID 41596740›Full record

ReviewInternational journal of molecular sciences2026

Zirconocene(III) in Organic Synthesis: Does the Ugly Duckling Become a Swan?

Jennifer Rosales, Rachid Chahboun, José Justicia

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jennifer RosalesDepartment of Organic Chemistry, Faculty of Sciences, University of Granada, C. U. Fuentenueva s/n, 18071 Granada, Spain.ORCID 0000-0002-9679-6343
Rachid ChahbounDepartment of Organic Chemistry, Faculty of Sciences, University of Granada, C. U. Fuentenueva s/n, 18071 Granada, Spain.ORCID 0000-0001-5303-1183
José JusticiaDepartment of Organic Chemistry, Faculty of Sciences, University of Granada, C. U. Fuentenueva s/n, 18071 Granada, Spain.ORCID 0000-0002-7712-0911

Funding

FEDER (EDRF)/Junta de Andalucía-Consejería de Universidad, Investigación e Innovación C-EXP-053-UGR23FEDER (EDRF)/Junta de Andalucía-Consejería de Universidad, Investigación e Innovación C-EXP-087-UGR23
6 · The paper itself

Abstract

The development of efficient C-C bond-forming reactions remains an important objective in organic chemistry. These reactions are fundamental tools for building complex molecules for diverse applications. Among the various strategies available, radical processes promoted by group IV metals-particularly Ti and its titanocene-type complexes-have shown remarkable versatility and utility in organic synthesis. However, closely related zirconium analogues have historically received less attention and have shown a more limited reactivity profile. Thus, zirconium and its zirconocene-type derivatives have often been regarded as the "ugly duckling" of group IV metal-promoted radical chemistry. Yet recent advances indicate that this "ugly duckling" is beginning to reveal its synthetic potential. In this review, we highlight the main synthetic applications of zirconocene(III) complexes and compare them with those of titanocene(III). Special attention is placed on the generation of reactive zirconocene(III) species and their impact on reactivity. Overall, these developments show how zirconocene(III) chemistry is emerging as a valuable complement to titanocene(III)-based radical transformations, turning our ugly duckling into a beautiful swan.

Indexed as

Organometallic CompoundsZirconiumOrganometallic CompoundstitanoceneZirconiumZirconocene dichloridefree radical chemistrymethodologysynthesistitanoceneZirconocene

Identifiers

PMID41596740
PMCPMC12841805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.